Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Saien Biotechnology is a Chinese life sciences company specializing in the research, development, and manufacturing of bioactive peptides, plant extracts, and health supplement raw materials. Founded in 2016 and based in the Shaanxi province, the company operates a comprehensive facility that integrates extraction, purification, and solid-phase peptide synthesis. Shaanxi Saien provides a broad catalog of products including research-grade peptide APIs such as Teriparatide and Ganirelix, as well as cosmetic ingredients and nutraceuticals like NMN and Ergothioneine. Beyond raw material supply, the company offers OEM and ODM services, providing one-stop solutions from formulation design to finished product manufacturing for global clients in the pharmaceutical and healthcare sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shaanxi Saien Biotechnology.